BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 719119)

  • 1. Application of the four-parameter logistic model to bioassay: comparison with slope ratio and parallel line models.
    Vølund A
    Biometrics; 1978 Sep; 34(3):357-65. PubMed ID: 719119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constrained four parameter logistic model.
    Altan S; Manola A; Davidian M; Raghavarao D
    Dev Biol (Basel); 2002; 107():71-6. PubMed ID: 12079194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivariate bioassay.
    Vølund A
    Biometrics; 1980 Jun; 36(2):225-36. PubMed ID: 6996751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Lack-of-Fit Assessment as a System Suitability Test for Potency Assays.
    Li R; Cai W; Zocher M
    PDA J Pharm Sci Technol; 2017; 71(5):368-378. PubMed ID: 28624777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical aspects of design and validation of microtitre-plate-based linear and non-linear parallel in vitro bioassays.
    Zimmermann H; Gerhard D; Dingermann T; Hothorn LA
    Biotechnol J; 2010 Jan; 5(1):62-74. PubMed ID: 19844917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fitting models for the joint action of two drugs using SAS.
    Whitehead A; Whitehead J; Todd S; Zhou Y; Smith MK
    Pharm Stat; 2008; 7(4):272-84. PubMed ID: 17979217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a real time PCR-based bioassay for quantification of neutralizing antibodies against human interferon-beta.
    Bertolotto A; Sala A; Caldano M; Capobianco M; Malucchi S; Marnetto F; Gilli F
    J Immunol Methods; 2007 Apr; 321(1-2):19-31. PubMed ID: 17335844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The five-parameter logistic: a characterization and comparison with the four-parameter logistic.
    Gottschalk PG; Dunn JR
    Anal Biochem; 2005 Aug; 343(1):54-65. PubMed ID: 15953581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a quantitative cell-based bioassay for comparing the pharmacokinetic profiles of two recombinant erythropoietic proteins in serum.
    Wei X; Grill DS; Heatherington AC; Swanson SJ; Gupta S
    J Pharm Biomed Anal; 2007 Jan; 43(2):666-76. PubMed ID: 16971087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivariate slope ratio assay with repeated measurements.
    Hui SL; Rosenberg SH
    Biometrics; 1985 Mar; 41(1):11-8. PubMed ID: 4005369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of multivariate parallel-line bioassay with composite responses and composite doses, using canonical correlations.
    Yuan W; Kshirsagar AM
    J Biopharm Stat; 1993 Mar; 3(1):57-71. PubMed ID: 8485536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring parallelism, linearity, and relative potency in bioassay and immunoassay data.
    Gottschalk PG; Dunn JR
    J Biopharm Stat; 2005; 15(3):437-63. PubMed ID: 15920890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model-free approach to estimation of relative potency in dose-response curve analysis.
    Guardabasso V; Rodbard D; Munson PJ
    Am J Physiol; 1987 Mar; 252(3 Pt 1):E357-64. PubMed ID: 3826362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technical comments on the bioassay of erythropoietin.
    Dunn CD; Napier JA
    Exp Hematol; 1978 Aug; 6(7):577-84. PubMed ID: 689123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A generalization of the probit and logit methods for dose response curves.
    Prentice RL
    Biometrics; 1976 Dec; 32(4):761-8. PubMed ID: 1009225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant information in bioassay and semi-parametric estimation.
    Kim PT; Lee CH
    Stat Med; 2005 May; 24(9):1421-33. PubMed ID: 15568193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parallel dose-response curves in combination experiments.
    Sühnel J
    Bull Math Biol; 1998 Mar; 60(2):197-213. PubMed ID: 9559575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of dose estimation from occupational exposure to 239Pu using different modelling approaches.
    Romanov SA; Guilmette RA; Khokhryakov VF; Phipps A; Aladova EE; Bertelli L; Birchall A; Eckerman KF; Khokhryakov VV; Krahenbuhl MP; Leggett RW; Little TT; Miller G; Miller SC; Riddell A; Suslova KG; Vostrotin VV; Zaytseva YV
    Radiat Prot Dosimetry; 2007; 127(1-4):486-90. PubMed ID: 18045798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixture models for continuous data in dose-response studies when some animals are unaffected by treatment.
    Boos DD; Brownie C
    Biometrics; 1991 Dec; 47(4):1489-504. PubMed ID: 1786327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal design and mathematical model applied to establish bioassay programs.
    Sánchez G; Rodríguez-Díaz JM
    Radiat Prot Dosimetry; 2007; 123(4):457-63. PubMed ID: 17182607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.